Next 10 |
2025-01-18 06:40:00 ET You can look at the momentum for some stocks and have a feeling that it's about to end. Others, though, have such strong underlying business prospects that they're practically unstoppable. Three Motley Fool contributors believe they've identified healthcare stoc...
2025-01-16 06:25:00 ET Summary In the fourth quarter of 2024, equity markets were positive and large cap stocks generally outperformed small cap stocks. Overall economic data continues to be mostly solid, and inflation continues to decline and is now approaching the Fed’s t...
2025-01-16 05:49:00 ET It usually doesn't matter if you buy a given stock immediately or two weeks later. Sure, the stock could move up or down but typically not enough to matter all that much. However, there are exceptions. Sometimes, a stock has a potential catalyst right around the c...
2025-01-15 19:20:34 ET Summary CRISPR Therapeutics' stock decline is likely influenced by Editas Medicine's struggles, but CRISPR remains a distinct and stronger company with a promising long-term outlook. CRISPR's strategic partnership with Vertex Pharmaceuticals has provided sta...
2025-01-15 16:00:44 ET The S&P 500’s health care sector ( NYSEARCA: XLV ), holding a weightage of 12.12% in the S&P 500 index, saw a fall of 10.2% in Q4 and is the fourth lowest scored sector by the SA Quant rating system.... Read the full article on Seeking Alp...
2025-01-14 04:34:00 ET If you're an investor searching for the next big market winners, Wall Street analysts have zeroed in on one biotech stock that could deliver huge gains in a defined time frame. Citing positive developments in its development programs, analysts from a couple of inv...
2025-01-14 02:07:00 ET Summary I last wrote here several months ago about the sodium channel (NaV1.8) inhibitor VX-548 (now known as suzetrigine), which is under investigation as a pain relief medication. In that earlier post on this drug, it had shown some very interesting (thoug...
2025-01-13 12:16:38 ET Vertex Pharmaceuticals Incorporated (VRTX) 43rd Annual J.P. Morgan Healthcare Conference January 13, 2025 10:30 AM ET Company Participants Dr. Reshma Kewalramani - President and CEO Charlie Wagner - Chief Financial Officer Stuart Arbuckle -...
2025-01-13 04:48:00 ET Arguably the three most important words in investing are: I don't know. Acknowledging that you don't know for sure what will happen with any investment can save you from a heap of trouble. However, this doesn't mean you can't have strong opinions about certain inv...
2025-01-11 15:06:44 ET More on Biogen, Gilead Sciences, etc. Eli Lilly: Still Expensive As Earnings Near, But Not Worthy Of A Downgrade Eli Lilly: Still Much Room To Ride The Weight-Loss Wave Novo Nordisk Vs. Eli Lilly: Obesity Makes Their Future Bright, But One Of T...
News, Short Squeeze, Breakout and More Instantly...
Vertex Pharmaceuticals Incorporated Company Name:
VRTX Stock Symbol:
NASDAQ Market:
Vertex Pharmaceuticals Incorporated Website:
2025-01-18 06:40:00 ET You can look at the momentum for some stocks and have a feeling that it's about to end. Others, though, have such strong underlying business prospects that they're practically unstoppable. Three Motley Fool contributors believe they've identified healthcare stoc...
2025-01-16 05:49:00 ET It usually doesn't matter if you buy a given stock immediately or two weeks later. Sure, the stock could move up or down but typically not enough to matter all that much. However, there are exceptions. Sometimes, a stock has a potential catalyst right around the c...
2025-01-14 04:34:00 ET If you're an investor searching for the next big market winners, Wall Street analysts have zeroed in on one biotech stock that could deliver huge gains in a defined time frame. Citing positive developments in its development programs, analysts from a couple of inv...